Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Growth Metrics

Ratios

Nu-Med Plus (NUMD) Long-Term Debt Repayments (2016 - 2017)

Nu-Med Plus' Long-Term Debt Repayments history spans 3 years, with the latest figure at -$27500.0 for Q1 2017.

On a quarterly basis, Long-Term Debt Repayments fell 125.7% to -$27500.0 in Q1 2017 year-over-year; TTM through Dec 2017 was -$27500.0, a 0.0% change, with the full-year FY2017 number at -$27500.0, changed 0.0% from a year prior.
Long-Term Debt Repayments hit -$27500.0 in Q1 2017 for Nu-Med Plus, roughly flat from -$27500.0 in the prior quarter.
Over the last five years, Long-Term Debt Repayments for NUMD hit a ceiling of $107000.0 in Q1 2016 and a floor of -$107000.0 in Q2 2016.